Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis
- PMID: 20333679
- DOI: 10.1002/ijc.25350
Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis
Abstract
It has been shown that injecting a suspension of IFN-γ-secreting tumor cells results in their rejection. This effect has been attributed to IFN-γ preventing tumor stroma formation but not to a direct effect on the cancer cells. However, it is not known, which influence IFN-γ has on tumors with an established stroma. To address this question, the plasmacytoma cell line J558L was transduced with a vector allowing doxycycline-inducible IFN-γ gene expression. After the injection of the tumor cells into mice, IFN-γ was induced at different time points. Tumors did not grow when inducing IFN-γ immediately after tumor cell inoculation, while approximately half of the tumors were rejected when IFN-γ was induced in early established tumors within 2 weeks. Induction of IFN-γ 2-3 weeks after tumor cell inoculation was less efficient (0-17% rejection). IFN-γ induction in established tumors led to a reduction of CD146(+) endothelial cells and massive necrosis. Together, we show that vascularized tumors can be rejected by local IFN-γ expression, but that rejection of established tumors was less efficient over time. This suggests that transplanted tumors became less susceptible to local IFN-γ treatment the better they are established.
Copyright © 2010 UICC.
Similar articles
-
IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.J Immunol. 1999 Jul 1;163(1):148-54. J Immunol. 1999. PMID: 10384111
-
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.Cancer Res. 2003 Jul 15;63(14):4095-100. Cancer Res. 2003. PMID: 12874012
-
IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.J Immunol. 2011 Oct 15;187(8):4219-28. doi: 10.4049/jimmunol.1100826. Epub 2011 Sep 14. J Immunol. 2011. PMID: 21918192 Free PMC article.
-
Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner.J Leukoc Biol. 2007 Feb;81(2):421-9. doi: 10.1189/jlb.0806489. Epub 2006 Oct 31. J Leukoc Biol. 2007. PMID: 17077163
-
The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis.Curr Opin Immunol. 2003 Apr;15(2):148-54. doi: 10.1016/s0952-7915(03)00007-4. Curr Opin Immunol. 2003. PMID: 12633663 Review.
Cited by
-
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu.Front Immunol. 2013 Nov 8;4:363. doi: 10.3389/fimmu.2013.00363. eCollection 2013. Front Immunol. 2013. PMID: 24265631 Free PMC article. Review.
-
Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1.Oncotarget. 2017 Jun 28;8(49):85024-85039. doi: 10.18632/oncotarget.18781. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156701 Free PMC article.
-
Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.Cancer Res. 2021 Jun 1;81(11):3092-3104. doi: 10.1158/0008-5472.CAN-20-2673. Epub 2021 Feb 11. Cancer Res. 2021. PMID: 33574087 Free PMC article.
-
MAIT Cells Modulate Innate Immune Cells and Inhibit Colon Cancer Growth.bioRxiv [Preprint]. 2024 Feb 2:2024.01.16.575894. doi: 10.1101/2024.01.16.575894. bioRxiv. 2024. Update in: Scand J Immunol. 2024 Sep;100(3):e13391. doi: 10.1111/sji.13391. PMID: 38293128 Free PMC article. Updated. Preprint.
-
Similar immune responses to alpha1-oleate and Bacillus Calmette-Guérin treatment in patients with bladder cancer.Cancer Med. 2024 Apr;13(7):e7091. doi: 10.1002/cam4.7091. Cancer Med. 2024. PMID: 38553868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources